Home » Topics » BioWorld Science

BioWorld Science
RSS

ZK-138723: Schering AG's aromatase inhibitor

June 14, 1996

RPR's Taxotere available in the U.S.

June 14, 1996

Navelbine on Canadian market

June 14, 1996

The Salk Institute for Biological Studies reveals immunophilin proteins

June 14, 1996

Astra reports autoimmune disease treatment agents

June 14, 1996

Generic formulation of Feldene approved

June 14, 1996

Pediatric clinical trials for Remune commence

June 14, 1996

GR-92754: Most effective DHFR inhibitor

June 14, 1996

Alferon LDO enters clinical trials

June 14, 1996

Additional AIDS gene therapy phase II trial

June 14, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...